PT  - JOURNAL ARTICLE
AU  - INGA STEINBERGA
AU  - KJELL JANSSON
AU  - BENGT SORBE
TI  - Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution
AID  - 10.21873/invivo.11632
DP  - 2019 Sep 01
TA  - In Vivo
PG  - 1521--1530
VI  - 33
IP  - 5
4099  - http://iv.iiarjournals.org/content/33/5/1521.short
4100  - http://iv.iiarjournals.org/content/33/5/1521.full
SO  - In Vivo2019 Sep 01; 33
AB  - Background/Aim: To investigate the overall survival rate, quality indicators and treatment outcome in FIGO stage IIIB-IVB epithelial ovarian cancer at a University Hospital in Sweden between 2006 and 2015. Materials and Methods: A cohort of 110 patients was followed-up for 3-12 years after cancer diagnosis. Three main groups (primary surgery, neoadjuvant chemotherapy, palliative treatment), and six subgroups were defined according to treatment modality. Results: The mean age was 65 years. Patients were observed for a mean of 50 months. The total resection frequency was 83%. Significant differences in overall survival at 5 years were observed between the groups varying from 60% to 12%. Conclusion: Patient age, tumor stage and complete tumor removal at surgery were significant, independent prognostic factors of overall survival. Complication rate was a significant adverse prognostic factor in univariate analysis. Data discrepancy was observed between public quality reports and locally obtained data.